Do insulin resistance, impaired hepatic lipid handling, endotoxin exposure, and low protein reserves reinforce low-grade metabolic inflammation?

Chronic low-grade metabolic inflammation is sustained by an interlocking, self-perpetuating feedback loop spanning the gut, liver, adipose, and immune systems.

Mechanistic pathways of endotoxemia and lipid clearance

• Endotoxin translocation: Gut-derived lipopolysaccharide (LPS) translocates into systemic circulation, binding to Toll-like receptor 4 (TLR4) on immune and metabolic cells. This triggers pro-inflammatory NF-κB and JNK cascades that drive chronic inflammatory states.
• Disrupted lipid handling: High-density lipoprotein (HDL) normally neutralizes LPS via "reverse LPS transport," delivering it to liver sinusoidal endothelial cells and scavenger receptor class B member 1 (SR-BI) for biliary excretion. Impairments in these hepatic lipid handling pathways halt this clearance process, allowing active endotoxins to accumulate and fuel systemic inflammation.

Amplification via insulin resistance and protein depletion

• Feed-forward insulin resistance: Circulating endotoxins directly promote insulin resistance through JNK and IKKβ activation. Conversely, insulin-resistant states elevate circulating free fatty acids and upregulate TLR4 expression, reinforcing the immune and metabolic activation.
• Compromised protein reserves: Chronic inflammation suppresses hepatic albumin synthesis, resulting in a low albumin-to-globulin ratio. This decline in protein reserves impairs the body's systemic antioxidant and buffering capacities, further cementing the inflammatory cycle.

Bottom line

• Low-grade metabolic inflammation is sustained by a highly integrated, feed-forward network where impaired hepatic lipid handling and gut-derived endotoxemia initiate TLR4-mediated inflammatory cascades, which are subsequently amplified and locked in place by insulin resistance and depleted protein reserves.